Alio to Participate in Upcoming Conferences

Alio to Participate in Upcoming Conferences

BROOMFIELD, Colo., March 4, 2022 / – Alio™, a medical technology company reinventing the management of chronic disease, announced today David Kuraguntla, Chief Executive Officer, will be presenting in upcoming investor and clinical-scientific conferences.


Life Science Market Research (LSI) US Meeting

March 15-18. 2022

Dana Point, California



Charing Cross International Symposium

April 26-28, 2022

London, United Kingdom



MedTech Strategist Innovation Summit

April 26-28, 2022

Dublin, Ireland



About Alio

Alio Medical™, a division of Alio, Inc. (Broomfield, CO), is a medical technology company developing SmartPatch™ technology and using artificial intelligence (AI) to monitor multiple chronic indications, including end stage kidney disease (ESKD) patients undergoing hemodialysis.  Alio is dedicated to the development of remote monitoring that provides actionable clinical data for a variety of conditions to better target interventions for improved outcomes and reduced hospitalizations.

Want to learn more?

Request a demo to see how it works